Patrick Tippoo has more than 30 years experience in the vaccine manufacturing industry.  He has been with Biovac, a private public partnership in South Africa, since its inception in 2003.  

His responsibilities at Biovac have included product development, strategic alliance partnering, international relations, projects and business development. Currently as Chief Science and Innovation Officer he is focused on growing Biovac’s product development capability and scientific & technical capacity as a centre of excellence for vaccine development and manufacture in Africa.
He is a founding member of the African Vaccine Manufacturing Initiative (AVMI) and is passionate about breaking Africa’s cycle of dependency and reliance on supply of much needed vaccines from outside Africa. He is a strong advocate for the establishment of vaccine development and manufacturing capacity in Africa. Patrick served as Vice President of the Developing Country Vaccine Manufacturers Network (DCVMN) from 2019-2022 and is Chair of the Emerging Biopharmaceuticals Manufacturing Network (EBPMN) board.  Patrick also leads the Vaccine Manufacturing Enterprise Working Group within the AU Covid-19 Commission.